Microfluidic affinity selection of active SARS-CoV-2 virus particles
View/ Open
Issue Date
2022-09-28Author
Gamage, Sachindra S. T.
Pahattuge, Thilanga N.
Wijerathne, Harshani
Childers, Katie
Vaidyanathan, Swarnagowri
Athapattu, Uditha S.
Zhang, Lulu
Zhao, Zheng
Hupert, Mateusz L.
Muller, Rolf M.
Muller-Cohn, Judy
Dickerson, Janet
Dufek, Dylan
Geisbrecht, Brian V.
Pathak, Harsh
Pessetto, Ziyan
Gan, Gregory N.
Choi, Junseo
Park, Sunggook
Godwin, Andrew K.
Witek, Malgorzata A.
Soper, Steven A.
Publisher
American Association for the Advancement of Science
Type
Article
Article Version
Scholarly/refereed, publisher version
Rights
Copyright © 2022 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S.Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY).
Metadata
Show full item recordAbstract
We report a microfluidic assay to select active severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral particles (VPs), which were defined as intact particles with an accessible angiotensin-converting enzyme 2 receptor binding domain (RBD) on the spike (S) protein, from clinical samples. Affinity selection of SARS-CoV-2 particles was carried out using injection molded microfluidic chips, which allow for high-scale production to accommodate large-scale screening. The microfluidic contained a surface-bound aptamer directed against the virus’s S protein RBD to affinity select SARS-CoV-2 VPs. Following selection (~94% recovery), the VPs were released from the chip’s surface using a blue light light-emitting diode (89% efficiency). Selected SARS-CoV-2 VP enumeration was carried out using reverse transcription quantitative polymerase chain reaction. The VP selection assay successfully identified healthy donors (clinical specificity = 100%) and 19 of 20 patients with coronavirus disease 2019 (COVID-19) (95% sensitivity). In 15 patients with COVID-19, the presence of active SARS-CoV-2 VPs was found. The chip can be reprogrammed for any VP or exosomes by simply changing the affinity agent.
Collections
Citation
Gamage, Sachindra S T et al. “Microfluidic affinity selection of active SARS-CoV-2 virus particles.” Science advances vol. 8,39 (2022): eabn9665. doi:10.1126/sciadv.abn9665
Items in KU ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
We want to hear from you! Please share your stories about how Open Access to this item benefits YOU.
Except where otherwise noted, this item's license is described as: Copyright © 2022 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S.Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY).